HIGHLIGHTS
- who: Edouard Louis from the Department of Gastroenterology, University and CHU Liu00e8ge, Liu00e8ge, Belgium Heart, Italy have published the article: Tailoring Biologic or Immunomodulator Treatment Withdrawal in Inflammatory Bowel Disease, in the Journal: (JOURNAL)
- what: The aims of this review article are to illustrate the most important factors to consider when contemplating treatment withdrawal in IBD and to propose a way to integrate these various factors. This study showed that the cost-effectiveness of continuous therapy was favorable at some drug cost thresholds. This model has been proposed and illustrated in a previous publication dealing . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.